LOCALLY ADVANCED INTRAHEPATIC CHOLANGIOCARCINOMA
Clinical trials for LOCALLY ADVANCED INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED INTRAHEPATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation beads plus immunotherapy: a new hope for inoperable bile duct cancer?
Disease control Recruiting nowThis early-phase trial is testing whether combining a targeted radiation treatment (Y90 radioembolization) with two immunotherapy drugs (durvalumab and tremelimumab) is safe and shows promise for people with bile duct cancer that cannot be removed by surgery. The study will enrol…
Matched conditions: LOCALLY ADVANCED INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for advanced bile duct cancer: liver transplant after targeted radiation
Disease control Recruiting nowThis study tests whether a liver transplant after a combination of targeted internal radiation (SIRT with Yttrium-90) and chemotherapy can improve 3-year survival in people with locally advanced intrahepatic cholangiocarcinoma (a type of bile duct cancer) that cannot be surgicall…
Matched conditions: LOCALLY ADVANCED INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC